Literature DB >> 24399354

Use of fidaxomicin through a nasogastric tube for the treatment of septic shock caused by Clostridium difficile infection in a patient with oral cancer admitted to the Surgical Critical Care Unit.

Emilio Maseda1, Carmen Hernandez-Gancedo, Araceli Lopez-Tofiño, Alejandro Suarez-de-la Rica, Silvia Garcia-Bujalance, Fernando Gilsanz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24399354

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN： 0214-3429            Impact factor:   1.553


× No keyword cloud information.
  4 in total

1.  Stability and recovery of DIFICID(®) (Fidaxomicin) 200-mg crushed tablet preparations from three delivery vehicles, and administration of an aqueous dispersion via nasogastric tube.

Authors:  Anna Tousseeva; J Derek Jackson; Mark Redell; Teresa Henry; Michael Hui; Shelley Capurso; C Andrew DeRyke
Journal:  Drugs R D       Date:  2014-12

Review 2.  A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management.

Authors:  Csaba Fehér; Josep Mensa
Journal:  Infect Dis Ther       Date:  2016-07-28

3.  A case report of successful management of clostridium difficile colitis with antegrade Fidaxomicin through a mucous fistula obviating the need for subtotal colectomy.

Authors:  Suzanne Arnott; Matthew Skancke; Sheena Chen; Bruce Abell
Journal:  Int J Surg Case Rep       Date:  2017-11-27

Review 4.  Clostridium difficile Infection in Special High-Risk Populations.

Authors:  Alberto Cózar-Llistó; Antonio Ramos-Martinez; Javier Cobo
Journal:  Infect Dis Ther       Date:  2016-08-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.